UBS Group
PETS icon

UBS Group’s PetMed Express PETS Stock Holding History

UBS Group’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,600
Closed -$629K – 10777
2022
Q2 		$629K Buy
31,600
+26,100
+475% +$583K ﹤0.01% 4085
2022
Q1 		$142K Buy
+5,500
New +$143K ﹤0.01% 5641
2015
Q1 		– Sell
-200
Closed -$3K – 9220
2014
Q4 		$3K Buy
+200
New +$2.69K ﹤0.01% 9256

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPH
Steel Partners Holdings New York $78M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group's PETS Position: Q2 2026 in Review

UBS Group reduced its PetMed Express (PETS) stake by 41% in Q2 2026, selling an estimated $202K and leaving 138,330 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #6634.

UBS Group first reported a position in PETS in Q4 2014 and has held it in 47 quarters since. The position peaked at $6.68M in Q1 2023. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • UBS Group held 138,330 shares of PetMed Express worth $266K as of Q2 2026.
  • UBS Group sold 95,346 PetMed Express shares in Q2 2026, an estimated $202K.
  • PetMed Express made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6634 holding.
  • UBS Group first reported a position in PetMed Express in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's PetMed Express position peaked at $6.68M in Q1 2023.
  • 50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.